Navigation Links
Hologic to Present at NASDAQ's 21st Investor Program in London
Date:5/20/2008

BEDFORD, Mass., May 20 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX) today announced that Jack Cumming, Chief Executive Officer will be presenting at the NASDAQ 21st Investor Program being held May 21, 2008 at the Andaz Hotel in London.

Interested parties are invited to listen to a live audio webcast of Hologic's investor presentation on Wednesday, May 21, 2008 at 10:45 a.m. BST on the investor section of the Company's website at http://www.hologic.com/investor. A replay of the webcast will be available approximately twenty-four hours following the presentations.

About Hologic

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, and mini C-arm for extremity imaging. For more information visit http://www.hologic.com.

Contact: Glenn P. Muir

Executive Vice President and CFO

Hologic, Inc.

(781) 999-7300

Frances Crecco

Director, Investor Relations

Hologic, Inc.

(781) 999-7377


'/>"/>
SOURCE Hologic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Hologic Announces Organizational Change
2. Can pathological techniques help identify primary colorectal signet ring cell carcinoma?
3. Electric shocks can cause neurologic and neuropsychological symptoms
4. Yerkes researchers find link between psychological stress and overeating
5. The choking game, psychological distress and bullying
6. Hologic to Present at the Bank Of America 2008 Smid Cap Conference
7. Hologic to Present at Lehman Brothers Healthcare Conference
8. Psychological intervention reduces postembolization pain
9. Correction: Therapist to Young Hollywood Says Male Stars in Psychological Trouble Get a Media Pass as Compared to Female Stars
10. Hologic to Present at the Raymond James & Associates 29th Annual Institutional Investors Conference
11. Guidelines for evaluation of psychological side-effects of brain injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 2016 , ... The Valentine’s Season is famous for gift giving with flowers, chocolates and other ... loved. This year, for more than 5.6 million Americans suffering with Alzheimer’s, those store ... to remind them of the lives they’ve led and the people they’ve touched. ...
(Date:2/8/2016)... ... 08, 2016 , ... Tingley Rubber Corporation , a ... its range of unique and advantaged protective solutions to a growing and ... bilingual customer service and marketing support. A new distribution center in Brampton, Ontario ...
(Date:2/8/2016)... ... February 08, 2016 , ... Delta Dental of California ... combat pancreatic cancer. , Gary D. Radine, who recently retired as president and CEO ... Cancer Society’s 2015 CEO of the Year , helped lead the effort to ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... wide variety of organizations. DocuSyst provides a cloud hosted environment for FileHold ... installations include integration with various 3rd party applications using the FileHold web services ...
(Date:2/8/2016)... , ... February 08, 2016 , ... TopConsumerReviews.com recently awarded ... Mole removal products. , Moles are derived from a cluster of melanin when exposed ... the wrong places and create a lifetime of embarrassment. Historically, mole removal ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... CITY, Calif., Feb. 8, 2016  Aoxing Pharmaceutical Company, Inc. (NYSE ... fiscal year 2016, ended December 31, 2015, the Company achieved ... recorded in the same quarter in fiscal 2015. ... in Q2 of fiscal year 2016 was $2,068,635, or $.03 ... or $.01 per share, in the Q2 of fiscal year ...
(Date:2/8/2016)... Feb. 8, 2016 ... of the "Label-Free Detection Market by ... 2020" report to their offering. ... addition of the "Label-Free Detection Market ... to 2020" report to their offering. ...
(Date:2/8/2016)...  HemaFlo Therapeutics, Inc. announced today that the United States ... 9,119,880 covering the use of NephroFlow to treat acute kidney ... founder, said, "We are pleased to secure our rights to ... , PhD, HemaFlo,s founder, said, "We are pleased to secure ... Dale Peterson , PhD, HemaFlo,s founder, said, "We ...
Breaking Medicine Technology: